Munich-Based Medtech Firm Prepares for Frankfurt Stock Exchange Debut
Germany’s Brainlab AG has announced its initial public offering (IPO) price range, setting shares between 80 and 100 euros each as it prepares to list on the Frankfurt Stock Exchange. The company aims for a market capitalization between approximately 1.67 billion and 2.09 billion euros as it enters the next phase of its expansion.[2][3][1]
Key Details of the IPO
- The IPO price range is set at 80 to 100 euros per share, translating to a valuation of between 1.67 billion and 2.09 billion euros for Brainlab.
- The offering will include both new shares — generating proceeds of up to 200 million euros to support commercialization and expansion — and up to 3.2 million secondary shares from existing shareholders.
- The IPO aims for a significant free float of up to approximately 26.6%, supporting trading liquidity on the open market.
- The offer period is expected to begin on June 24, 2025, and conclude on July 1, 2025, with shares poised to start trading on July 3, 2025, pending regulatory approval.
Growth Strategy and Use of Proceeds
The company plans to use the IPO capital to accelerate the commercial rollout of fully integrated workflows, expand into new clinical applications, and move into adjacent market segments. This step is expected to solidify Brainlab’s leading position as a pioneer in medical technology software.
Regulatory Approval and Offer Conditions
The offering and subsequent stock market listing are contingent on the approval and publication of Brainlab’s prospectus by the German Federal Financial Supervisory Authority (BaFin). Full trading is anticipated on the Prime Standard segment of the Frankfurt Stock Exchange.
Further Information
For more on Brainlab’s technology and strategic vision, visit the company’s official announcements and financial disclosures. For details on the IPO process, refer to the Frankfurt Stock Exchange listing regulations and the German regulator, BaFin.
For readers interested in AI platforms like
ChatGPT, which are transforming industries including healthcare, follow the latest developments on dedicated resources.
